Jasper Therapeutics

Jasper Therapeutics

JSPR

Reported
Thursday, February 27

Q4 2024 Earnings

(USD)ExpectedReportedSurprise $Surprise %
EPS-1.26-1.62-0.36-28.57%
Revenue-0.00--
WhatIF - Earnings
EPS Missed Expectations by -$0.36
emptyImageAlt
Jasper Therapeutics (JSPR:NASDAQ) has never missed EPS by this much before
There’s a first time for everything